Neurology

From neuroimmunology to Alzheimer’s disease and dementia testing, neurological testing can help provide answers

Behind every sample is a life—a life filled with questions. We help provide answers with our broad menu of over 400 neurology tests, including a full portfolio for Alzheimer’s disease and dementia testing, as well as expansive testing for complex neuroimmunological diseases and other neurological conditions.

Insights to help improve outcomes

The complexity of the neurological system and the absence of a specific clinical presentation make it difficult to know where to look first. In most cases, early detection and prompt therapy can improve patient outcomes.¹ We offer a comprehensive neurological testing portfolio, including blood and CSF testing methods, so you can provide the answers and care your patients deserve.

FEATURED TEST

QUEST AD-Detect™ Amyloid Beta 42/40 Ratio

Assessing risk for Alzheimer’s disease, the most common form of dementia

Alzheimer’s disease affects over 6M people in the US² and may contribute to up to 70% of cases of dementia.³ Quest offers a simple blood-based, easily accessible risk assessment options that can directly impact your care pathway.

Your source for autoimmune neurology testing

Neuroimmunological diseases are complex. Testing for them shouldn’t be. Quest Advanced^® Neurology has expanded offerings for several autoimmune neurological disorders and makes testing more accessible and actionable.

Image showing doctor talking with a patient

FEATURED TESTS

Broad neuroimmunology menu

Expansive test menu includes over 40 antibodies

Our neuroimmunology portfolio includes testing for myasthenia gravis, paraneoplastic syndromes, autoimmune encephalitis, neuromyelitis optica, peripheral neuropathy, and multiple sclerosis. Our expansive test menu includes over 40 antibodies and utilizes gold-standard methodologies, such as CBA, RIA, and line blot.⁴

We help eliminate the unknowns

No matter where each patient is on the diagnostic journey, our complete portfolio of molecular, biochemical, neuroimmunological, and cytogenetic testing can help you and your patient move forward with clarity and confidence.

Watch Video

A comprehensive range of neurology testing, powered by 15 distinct methodologies

In the US, 1 in 9 people over 65 has Alzheimer’s disease,² but there is evidence that early detection and emerging treatments can lessen its impact.

Quest Advanced^® Neurology offers a full portfolio of industry-leading diagnostics to assess the risk of Alzheimer’s disease and dementia, whether your patient has a family history or not.

Patients showing mild cognitive impairment where Alzheimer's disease is suspected

Patients across the spectrum of cognitive decline with or without a suspicion of Alzheimer's disease

One-time assessment for patients who may have a family history Alzheimer's disease

Learn more

Research shows that early interventions for ASD and developmental delay can greatly improve a child’s development. We offer AAP guideline-based chromosomal microarray analysis (CMA),⁵ which has the highest diagnostic yield of any single test for children that is currently available to clinicians.

View our CMA brochure
Access our CMA prior authorization form

IEM happen when a genetic defect disrupts the body’s metabolic pathway—causing conditions such as vitamin deficiencies, organic acidemia, and peroxisomal disorders. Because the balance between undertreatment and overtreatment can be precarious, ongoing monitoring is essential. Get the insights you need to manage IEM-derived challenges with our comprehensive genetic test menu and on-demand expertise from genetic counselors.

Learn more about IEM and the Quest IEM test portfolio
View our porphyria testing FAQs
Visit the Test Directory for information on our Porphyria Laboratory Evaluation

Identify a patient’s unique stroke risk and take action by assessing their metabolic and cardiovascular risk profile. Quest offers a full range of stroke testing that can help inform care plans and treatment monitoring.

Learn more

The power of Quest

Innovative solutions

Our goal is to provide insights that fuel action, which is why we continually expand the breadth of our testing and complement the cutting-edge with the creativity of the human mind, never hesitating to provide formidable resources for the care of every patient.

Improved experiences

Whether we’re working with patients or providers, accessibility is always our priority. And with testing solutions that lend clarity to complexity, we pride ourselves on reimagining our systems to be more seamless, intuitive, and insightful than ever before.

Better outcomes

Every test offers an opportunity to improve a patient’s life. That’s why we leverage our extensive in-house expertise to empower providers with tools and technology to give patients the answers they deserve.

The right price

We are your ally, which means we always work hard to ensure cost never compromises care. We are committed to making our industry-leading diagnostics the best value anywhere.

References

Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 2011;10(8):759-772. doi:10.1016/S1474-4422(11)70096-5
Alzheimer’s Association. 2023 Alzheimer’s Disease Facts and Figures. 2023. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf
WHO. Dementia. March 15, 2023. Accessed July 5, 2023. https://www.who.int/news-room/fact-sheets/detail/dementia
Stocker W, Probst C, Teegen B, et al. Multiparameter autoantibody screening in the diagnosis of neurological autoimmune diseases. Paper presented at: 1st Congress of the European Academy of Neurology (EAN); June 2015; Berlin, Germany.
Sathirapongsasuti JF, Lee H, Horst BA, et al. Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics. 2011;27(19):2648-2654. doi:10.1093/bioinformatics/btr462
CDC. Accelerating risk reduction and promoting brain health. Updated July 29, 2019. Accessed May 18, 2023. https://www.cdc.gov/aging/healthybrain/issue-maps/risk-reduction.html

Join our email community

Get the very latest news and information from Quest Advanced^® Neurology.

About our tests

Resources

LinkedIn: Quest Advanced Neurology

Common ICD-10 codes for neurology

Join our LinkedIn community

Get the latest on how Quest Advanced Neurology is providing insights that fuel action.

Follow Quest Advanced Neurology on LinkedIn

Leverage our broad test menu

Quest provides a comprehensive test menu of neurological diagnostic testing, including tests used for epilepsy, dementia, paraneoplastic disorders, multiple sclerosis, and myasthenia gravis.

Visit the Test Directory to learn more